J&J’s $8.2 Billion Talc Settlement Faces January Court Test

  • Lawyers are sparring over the voting that backed the accord
  • A federal judge in Houston to rule on the 15-year legal battle
Johnson & Johnson baby powder at a pharmacy in New York, on March 27, 2024. Photographer: Gabby Jones/Bloomberg
Lock
This article is for subscribers only.

The fate of Johnson & Johnson’s latest push to use bankruptcy courts to end thousands of cancer lawsuits tied to its iconic baby powder now hinges on a high-stakes trial in January.

After months of wrangling, a federal judge in Houston early next year will decide whether J&J’s bid to quickly settle the claims with an $8.2 billion payout can move ahead. A lead attorney for holdouts insists a vote by claimants in support of the deal was rigged, a charge that J&J denies.